Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Diagnos
Brossard, Quebec, Canada
- Ownership
- Private
- Development stage
- Other
01
Overview
Diagnos provides an AI- and machine learning–based, cloud and telemedicine-enabled retinal image analysis platform (CARA) that is commercially deployed in at least 15 countries with regulatory certifications in the U.S., Canada, EU, and Mexico for screening and early detection of diabetic retinopathy and other retinal disease, with ongoing clinical validation studies such as a three‑year trial at the University of Montreal Hospital Centre (CHUM) for the NeoRetina algorithm[1][2][3].
- Therapeutic areas
- Ophthalmology
- Modalities
- DeviceNon-pharmacological therapySoftware as a medical device
- Industry
- Digital Health Medical Devices
02
Partnerships
Center Hospitalier de l’Université de Montréal (CHUM) – three-year clinical and AI collaboration on retinal diseases including diabetic retinopathy[2].Magrabi Hospitals & Centers (Saudi Arabia) – rollout of CARA screening clinics across multiple hospitals in Saudi Arabia and planned expansion in MENA[2].Devlyn Grupo (Mexico and Guatemala) – use of CARA for diabetic retinopathy screening in optical retail locations[3].Chaparral Medical Group (Southern California, USA) – multi‑year teleophthalmology screening agreement[3].Colombian Telemedicine Centre Ltd (CTMC) – national screening collaboration in Colombia[3].Labtician Ophthalmics (Canada) – use of AI solution to monitor ocular health in diabetic patients[3].Government of Quebec – Economic Development Fund interest‑free loan to support CARA commercialization[3].
Beyond the preview
Go deeper on Diagnos.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Diagnos.